Showing results (1-10 of 3,674) with videos related to

Sort By:
Pageof 368
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1987
Long-term survivors on peritoneal dialysisS W Zimmerman, C A Johnson, M O'Brien
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Intraperitoneal Vancoled does not cause chemical peritonitisC A Johnson, S W Zimmerman, S Engeseth, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1991
Erythropoietin use in peritoneal dialysis patientsS W Zimmerman, C A Johnson
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving EPOGENC A Johnson, E Rosowski, S W Zimmerman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1984
The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitisC A Johnson, S W Zimmerman, M Rogge
Nephron|January 1, 1984
Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patientsC A Johnson, P G Welling, S W Zimmerman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1991
Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infectionsS W Zimmerman, E Ahrens, C A Johnson, et al.
Clinical Nephrology|March 1, 1985
Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysisC A Johnson, S W Zimmerman, W Bayer, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1995
Serum advanced glycosylation end-products in patients on hemodialysis and CAPDA Ateshkadi, C A Johnson, H W Founds, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 12, 1999
Pharmacokinetics of intraperitoneal epoetin alfa in patients on peritoneal dialysis using an 8-hour "dry dwell" dosing techniqueC A Taylor, M R Kosorok, S W Zimmerman, et al.
Pageof 368